Astronomers Accidentally Stumble Upon an ‘Invisible’ Galaxy The literal path to stardom isn’t inevitable. Inverse · Jan 9, 2024
Lanarkshire charity hosts range of activities to mark Mental Health Awareness Week Getting Better Together (GBT) in Shotts aimed to combat the anxiety that many of us feel by bringing the community together and offering sessions which focus on health and well-being. Daily Record · May 21, 2023
Shotts group enjoy big win at the seaside as part of Befrienders Week The Getting Better Together team enjoyed a trip away to Blackpool and a big win at the bingo Daily Record · Nov 14, 2022
5 Income Stocks to Turn to When Times Are Tough The S&P 500 is coming off its four-week win streak amid signals of cooling price increases. However, inflation is still running hot near a 40-year high, which might induce the Fed to continue its policy rate hikes. We think income stocks AbbVie (ABBV), Amgen (AMGN), Pfizer (PFE), Bristol-Myers Squibb (BMY),… StockNews.com · Aug 16, 2022
Construction work starts on new community hub in Shotts The redeveloped building will become a modern space with facilities for a wide range of activities and events Daily Record · Aug 8, 2022
Benzinga Before The Bell: Elon Musk Confirms Tesla AI Day Part 2, Dogecoin Scam, BioNTech Q2 Earnings Shocker And Other Top Financial Stories Monday, August 8 CNBC Celsius Withdraws Motion To Rehire CFO Benzinga · Aug 8, 2022
Looking Into Global Blood Therapeutics's Return On Capital Employed According to Benzinga Pro data, during Q1, Global Blood Therapeutics (NASDAQ:GBT) posted sales of $55.16 million. Earnings were up 7.03%, but Global Blood Therapeutics still reported an overall loss of $81.42 million. Benzinga · Jun 28, 2022
New project in Shotts provides youngsters with bike maintenance skills Getting Better Together (GBT) received £24,165 through walking charity Paths for All’s Smarter Choices, Smarter Places (SCSP) COP26 Legacy Fund. Daily Record · Jun 20, 2022
Global Blood Therapeutics Earnings Perspective: Return On Capital Employed According to data from Benzinga Pro, during Q1, Global Blood Therapeutics's (NASDAQ:GBT) reported sales totaled $55.16 million. Despite a 7.03% increase in earnings, the company posted a loss of $81.42 million. Benzinga · May 20, 2022
Recap: Global Blood Therapeutics Q1 Earnings Global Blood Therapeutics (NASDAQ:GBT) reported its Q1 earnings results on Wednesday, May 4, 2022 at 04:05 PM. Here's what investors need to know about the announcement. Benzinga · May 4, 2022
Recap: Global Blood Therapeutics Q4 Earnings Global Blood Therapeutics (NASDAQ:GBT) reported its Q4 earnings results on Wednesday, February 23, 2022 at 04:05 PM. Here's what investors need to know about the announcement. Benzinga · Feb 23, 2022
Stock Wars: Axsome Therapeutics Vs. Global Blood Therapeutics Benzinga’s weekly Stock Wars matches up two leaders in a major industry sector with the goal of determining which company is the better investment. Benzinga · Feb 2, 2022